Clinical Trials Browser

Phase 1 × Non-Muscle Invasive Bladder Neoplasms × Gemcitabine × Clear all

NCT05375903 2026-01-14

A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Phase 1 Completed

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms